Drugs / SMARTO ONE
last change Dec 2024 re-read 3 minutes ago

SMARTO ONE

Developed for
neurodegenerative disease
Investigated by
Mei Han

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT05947409 Aug 2023 → Jun 2024 neurodegenerative disease Mei Han Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SMARTO ONE ClinicalTrials.gov intervention name — accepted as the source's own label NCT05947409 ↗